Centessa Pharmaceuticals plc (CNTA) Event May 16, 2022, 00:00 UTC (75% Positive) CENTESSA PHARMACEUTICALS PLC (CNTA) Reports 100% Loss Reduction for 2022-03-31 Full text
Register to leave comments News bot Oct. 29, 2025, 9 a.m. 🏢 Centessa Pharmaceuticals plc (CNTA) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-05-16 📊 Period of Report: 2022-03-31 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $-829.00K $-238.69M $237.86M +99.65% 📉 Total Assets $629.63M $582.19M $47.45M +8.15% 📈 Total Liabilities $138.08M $102.04M $36.04M +35.32% 📉 Stockholders' Equity $278.63M $-243.27M $521.91M +214.54% 📈 Operating Income/Loss $-783.00K $-236.19M $235.41M +99.67% 📉 Earningspersharebasic $-4.97 $-0.60 $-4.37 -728.33% 📉 Earningspersharediluted $-4.97 $-0.60 $-4.37 -728.33% 📉 📈 Financial Trend Analysis 🔻 Reported net loss for the period • ⚖️ Liability growth outpaced asset growth 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 Centessa Pharmaceuticals plc (CNTA) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🔻 Reported net loss for the period • ⚖️ Liability growth outpaced asset growth
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document